Market Indices
Sector Heatmap
PTHS — Pelthos Therapeutics Inc.
NYSE AmericanPelthos Therapeutics Inc.
- O
- 21.43
- H
- 21.99
- L
- 20.99
- V
- 17.66K
PTHS — Latest News & Headlines
8 StoriesFor estimated vesting taxes, a Pelthos Therapeutics (PTHS) director sold 786 shares at $21. - Stock Titan
For estimated vesting taxes, a Pelthos Therapeutics (PTHS) director sold 786 shares at $21. Stock Titan
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Stock: Insider Peter Greenleaf Sells 797 Shares - MarketBeat
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Stock: Insider Peter Greenleaf Sells 797 Shares MarketBeat
Pelthos Therapeutics director sells $11,560 in common stock - Investing.com
Pelthos Therapeutics director sells $11,560 in common stock Investing.com
Under a trading plan, Pelthos Therapeutics (PTHS) director sells 797 shares at $21.17. - Stock Titan
Under a trading plan, Pelthos Therapeutics (PTHS) director sells 797 shares at $21.17. Stock Titan
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Sells 558 Shares of Stock - MarketBeat
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Sells 558 Shares of Stock MarketBeat
Stockholders elect eight directors as Pelthos Therapeutics (PTHS) adopts its 2026 stock incentive plan. - Stock Titan
Stockholders elect eight directors as Pelthos Therapeutics (PTHS) adopts its 2026 stock incentive plan. Stock Titan
Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock - Investing.com
Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock Investing.com
Pelthos Therapeutics director Matthew Pauls sells $16,506 in shares - Investing.com
Pelthos Therapeutics director Matthew Pauls sells $16,506 in shares Investing.com